Thamer Bin Traiki
Papers
1
Total Citations
2
H-Index
1
About
Dr. Thamer Bin Traiki is a leading surgical oncologist whose research focuses on advancing minimally invasive approaches for peritoneal surface malignancies, particularly through cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). His major contribution lies in demonstrating the feasibility and safety of robotic and laparoscopic techniques for these complex procedures, challenging traditional open surgery paradigms. His landmark multicenter study from Saudi Arabia (2024), though early in citation impact, provides critical evidence that minimally invasive CRS/HIPEC can achieve comparable oncologic outcomes with reduced morbidity, a finding that has the potential to reshape global treatment protocols. Dr. Bin Traiki’s work addresses a critical gap in surgical oncology, offering patients with peritoneal metastasis a less invasive path to aggressive multimodal therapy. His collaborative, multicenter approach underscores his commitment to generating robust, reproducible data that can guide clinical practice. As his research gains traction, it is poised to influence both surgical training and patient selection criteria, marking him as a rising authority in the field of advanced laparoscopic and robotic oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1